BackgroundT-cells play an important role in the immune response and are activated in response to the presentation of antigens bound to major histocompatibility complex (MHC) molecules participating with the T-cell receptor (TCR). T-cell receptor complexes also contain four CD3 (cluster of differentiation 3) subunits. The TCR-CD3 complex is vital for T-cell development and plays an important role in intervening cell recognition events. Since microRNAs (miRNAs) are highly stable in blood serum, some of which may target CD3 molecules, they could serve as good biomarkers for early cancer detection. The aim of this study was to see whether there is a relationship between cancers and the amount of miRNAs -targeted CD3 molecules.MethodsBioinformatics tools were used in order to predict the miRNA targets for these genes. Subsequently, these highly conserved miRNAs were evaluated to see if they are implicated in various kinds of cancers. Consequently, human disease databases were used. According to the latest research, this study attempted to investigate the possible down- or upregulation of miRNAs cancer patients.ResultsWe identified miRNAs which target genes producing CD3 subunit molecules. The most conserved miRNAs were identified for the CD3G gene, while CD247 and CD3EAP genes had the least number and there were no conserved miRNA associated with the CD3D gene. Some of these miRNAs were found to be responsible for different cancers, following a certain pattern.ConclusionsIt is highly likely that miRNAs affect the CD3 molecules, impairing the immune system, recognizing and destroying cancer tumor; hence, they can be used as suitable biomarkers in distinguishing cancer in the very early stages of its development.
IntroductionColorectal cancer (CRC) is one of the most common malignancies worldwide. The expression of CLCA4, a tumor suppressor gene, decreases significantly in cancer cells of CRC. In this study, we identified miRNAs target the mRNA of the CLCA4 gene. ObjectiveThe aim of this study was the identification of miRNAs involved in CRC.Material and methodsWe predicted miRNA(s) that target CLCA4 mRNA applying TargetScan v.7. Then through analysis of Gene Expression Omnibus (GEO) datasets, among them, miRNA(s) over-expressed in CRC cells were determined. To identify miRNAs with the highest potential to down-regulate CLCA4 through binding, we calculated the binding free energies of the candidate miRNA- mRNA complexes using the molecular mechanics energies combined with several solvation models: The Poisson–Boltzmann (MM/PBSA), the generalized Born (MM/GBSA), and the three-dimensional reference interaction site model with Kovalenko–Hirata closure relation (3D-RISM-KH). ResultsOur TargetScan analysis predicted that 106 miRNAs could bind to CLCA4 3' UTR mRNA. Hsa-miR-934, hsa-miR-574-5p, hsa-miR-377-3p, hsa-miR-5580-3p, hsa-miR-4775, hsa-miR-590-3p and hsa-miR-501-5p showed increased expression in CRC samples compared to normal cells. MD results found the lowest free energy changes in three hsa-miR-377-3p, hsa-miR-574-5p and hsa-miR-501-5p miRNAs. ConclusionThis research beside introducing a new fast and low cost plan to find best candidate of miRNAs to bind their targets, suggested miR-501-5p as a biomarker for early diagnosis of CRC. As well, preventing of down regulation of the CLCA4 expression through interrupting in the expression of miR-574-5p and miR-377-3p and more effectively miR-501-5p probably treat or slow down the development of colorectal cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.